RxDoctor Payments Data

Andrew Lister, DO

Psychiatry · North Port, FLNPI 1992167191

Payments from drug & device makers

$745in general payments, 2019–2025

Across 38 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$127
  • Alkermes, Inc.$75
  • Teva Pharmaceuticals USA, Inc.$66
  • Corium, LLC$63
  • Almatica Pharma LLC$62
  • Otsuka America Pharmaceutical, Inc.$49
  • plus $303 from 9 others

What the payments were for

  • Food & beverage$745100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$745 in reported general payments places this provider in the 55th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$44,902
Medicare patients
56
Services billed
451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate14$119,294
RexultiBrexpiprazole12$20,074
Aripiprazole51$8,686
BelsomraSuvorexant19$6,964
VyvanseLisdexamfetamine Dimesylate17$6,532
Vilazodone Hcl18$3,275
Quetiapine Fumarate119$2,351
Paroxetine Hcl38$2,068
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine39$1,781
Alprazolam252$1,739
Bupropion XlBupropion Hcl87$1,733
Duloxetine Hcl54$1,415
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine19$1,164
Trazodone Hcl126$1,065
Carbamazepine ErCarbamazepine12$968

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$14$119,29414 claims
Otsuka America Pharmaceutical, Inc.Rexulti$49$20,07412 claims
Almatica Pharma LLCSertraline Hcl$62$538106 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in North Port

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →